Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|June 1, 1998
Supplements and Featured Publications
- Treatment of Heart Failure: A Managed Care Perspective
- Volume 4
- Issue 6 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 28 years ago
Introduction: Treatment of Heart Failure: A Managed Care Perspectiveover 28 years ago
Epidemiology, Prevalence, Treatments, and Clinical Trialsover 28 years ago
Clinical Practice Guidelines for Heart Failureover 28 years ago
Cost of Heart Failure to the Healthcare Systemover 28 years ago
Heart Failure and Disease Managementover 28 years ago
Selected Abstractsover 28 years ago
CME Quizover 28 years ago
BibliographyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
Primary Care Capacity Gaps Threaten Respiratory Prevention
3
COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says
4
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
5